Medical Marijuana Evaluation for Crohn's Disease in Washington State
Washington State medical marijuana evaluations for Crohn's disease and IBD. Same-day appointments with WA-licensed physicians — no referral needed.
About Crohn's Disease & IBD and Medical Cannabis
Crohn's disease and inflammatory bowel disease (IBD) are recognized qualifying conditions under Washington's RCW 69.51A. Patients with Crohn's disease, ulcerative colitis, and related IBD conditions who are managing symptoms such as pain, nausea, and weight loss may be eligible for a medical marijuana evaluation in Washington State.
Why Patients with Crohn's Disease & IBD Seek a Medical Cannabis Evaluation
Patients with Crohn's disease and IBD frequently report seeking medical cannabis evaluations to explore additional options for managing pain, nausea, appetite, and quality of life. Research into cannabinoids and gastrointestinal conditions is ongoing. Your evaluating physician can discuss the current state of evidence as it applies to your specific diagnosis and symptom pattern.
This information is for educational purposes only and does not constitute medical advice. Authorization requires an evaluation by a licensed Washington State physician who will determine whether medical cannabis is appropriate for your individual situation.
Medical Cardholders Save Up to 47% on Every Purchase
Under Washington's HB 1453 (effective June 2024–June 2029), patients with a valid medical authorization are exempt from the 37% cannabis excise taxplus local sales tax on qualifying DOH-compliant products. Depending on your county, that's up to 47% off every dispensary purchase.
$50/wk spend
~$960/yr
estimated savings
$100/wk spend
~$1,920/yr
estimated savings
$200/wk spend
~$3,840/yr
estimated savings
What to Expect at Your Evaluation
Your Crohn's or IBD diagnosis serves as your primary qualification basis. Bring records from your gastroenterologist if available — colonoscopy results, biopsy reports, or imaging are helpful. Records are not required. Your physician will review your symptom pattern, current medications (including biologics), and determine whether medical cannabis is appropriate for your individual case.
Common Questions About Crohn's Disease & IBD and Medical Cannabis
Does ulcerative colitis also qualify?
Both Crohn's disease and ulcerative colitis fall within the IBD category that qualifies under Washington's RCW 69.51A. Your physician will make an individual determination.
Can cannabis interact with biologics like Humira or Entyvio?
Cannabis is generally considered compatible with biologic therapies, but our physicians will review your full medication list at your appointment.
Do I need to be in a flare to qualify?
No. Your ongoing diagnosis and symptom history are what matter. Patients in remission with residual symptoms may also be evaluated.
How does the medical card help financially?
Medical cardholders are exempt from Washington's 37% cannabis excise tax and local sales tax on qualifying products. For patients using cannabis regularly, this can represent hundreds to thousands of dollars in annual savings.
Ready to Get Your Authorization?
Same-day appointments with WA-licensed physicians. No referral needed. In-person and telehealth options available.
Get authorized for Crohn's Disease & IBD via telehealth
Returning patients can renew from anywhere in Washington. New patients may qualify for telehealth in some circumstances — book online and we'll confirm at scheduling.
View all telehealth locationsOther qualifying conditions
Patient Guide
Medical Marijuana for Crohn's Disease in Washington State
Crohn's disease qualifies for Washington State medical marijuana. Learn how cannabis helps manage Crohn's symptoms, what the research shows, and how to get your authorization.
Read the guide →